|1.||Goulmy, Els: 3 articles (03/2009 - 01/2003)|
|2.||Hambach, Lothar: 2 articles (03/2009 - 09/2008)|
|3.||Aghai, Zohara: 2 articles (03/2009 - 09/2008)|
|4.||Pool, Jos: 2 articles (03/2009 - 01/2003)|
|5.||van Boven, Hester: 1 article (03/2009)|
|6.||Blokland, Els: 1 article (03/2009)|
|7.||Tanke, Hans J: 1 article (03/2009)|
|8.||Bruijn, Jan A: 1 article (03/2009)|
|9.||Halfwerk, Hans: 1 article (03/2009)|
|10.||Ling, Kam-Wing: 1 article (03/2009)|
03/19/2009 - "The mHag HA-1 is aberrantly expressed in cancers of most entities. "
09/01/2008 - "The mHag HA-1 is hematopoiesis restricted, but displays additionally an aberrant expression on solid tumors. "
09/01/2008 - "Here, we show that cytotoxic T lymphocytes (CTLs) solely targeting the human mHag HA-1 are capable of eradicating 3-dimensional human solid tumors in a highly mHag-specific manner in vitro, accompanied by interferon-gamma release. "
|2.||Graft vs Host Disease (Graft-Versus-Host Disease)
07/01/2000 - "Disparities in minor histocompatibility antigen (mHAg) HA-1 are involved in the development of acute graft-versus-host disease (GvHD) in adult recipient after HLA-identical sibling donor hematopoietic stem cell transplantation. "
02/13/1998 - "The minor histocompatibility antigen (mHag) HA-1 is the only known mHag for which mismatching is correlated with the development of severe graft versus host disease (GvHD) after human leukocyte antigen-identical bone marrow transplantation. "
|3.||Hematologic Neoplasms (Hematological Malignancy)
|1.||Histocompatibility Antigens (Histocompatibility Antigen)
|3.||Interferon-gamma (Interferon, gamma)
|1.||Hematopoietic Stem Cell Transplantation
|2.||Bone Marrow Transplantation (Transplantation, Bone Marrow)